Page last updated: 2024-08-25

bendamustine hydrochloride and Acute Lymphoid Leukemia

bendamustine hydrochloride has been researched along with Acute Lymphoid Leukemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Butera, J; Egan, P; MacKinnon, K; Margolis, J; McMahon, J; Ollila, T; Olszewski, AJ; Reagan, J; Rosati, V; Thomas, A; Yakirevich, I1
Ahn, HS; Aplenc, R; Bensen-Kennedy, D; Brown, P; Cho, B; Frankel, L; Fraser, C; Harker-Murray, P; Kirov, I; Megason, G; Munteanu, M; Weaver, J1
Cerny-Reiterer, S; Gleixner, KV; Hadzijusufovic, E; Herrmann, H; Jäger, U; Maeda, H; Melo, JV; Meyer, RA; Peter, B; Pickl, WF; Sperr, WR; Stefanzl, G; Valent, P1
Bond, M; Darwish, M; Grasela, T; Hellriegel, E; Megason, G; Phillips, L; Robertson, P1
Goto, H; Goto, S; Yokosuka, T1

Trials

3 trial(s) available for bendamustine hydrochloride and Acute Lymphoid Leukemia

ArticleYear
Vincristine Sulfate Liposome Injection with Bendamustine and Rituximab as First-Line Therapy for B-Cell Lymphomas: A Phase I Study.
    The oncologist, 2022, 07-05, Volume: 27, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Bendamustine Hydrochloride; Humans; Ileus; Liposomes; Lymphoma, B-Cell; Lymphopenia; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rituximab; Vincristine

2022
Open-label bendamustine monotherapy for pediatric patients with relapsed or refractory acute leukemia: efficacy and tolerability.
    Journal of pediatric hematology/oncology, 2014, Volume: 36, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Child; Child, Preschool; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Nitrogen Mustard Compounds; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence

2014
Population pharmacokinetics and pharmacokinetics/pharmacodynamics of bendamustine in pediatric patients with relapsed/refractory acute leukemia.
    Current medical research and opinion, 2014, Volume: 30, Issue:11

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents, Alkylating; Area Under Curve; Bayes Theorem; Bendamustine Hydrochloride; Child; Child, Preschool; Cohort Studies; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Middle Aged; Nitrogen Mustard Compounds; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Young Adult

2014

Other Studies

2 other study(ies) available for bendamustine hydrochloride and Acute Lymphoid Leukemia

ArticleYear
Identification of heat shock protein 32 (Hsp32) as a novel target in acute lymphoblastic leukemia.
    Oncotarget, 2014, Mar-15, Volume: 5, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Bendamustine Hydrochloride; Benzamides; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Gene Knockdown Techniques; Heme Oxygenase-1; Humans; Imatinib Mesylate; Maleates; Metalloporphyrins; Nitrogen Mustard Compounds; Philadelphia Chromosome; Piperazines; Polyethylene Glycols; Polystyrenes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; RNA, Messenger

2014
The combination effects of bendamustine with antimetabolites against childhood acute lymphoblastic leukemia cells.
    International journal of hematology, 2016, Volume: 103, Issue:5

    Topics: Adenine Nucleotides; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Bendamustine Hydrochloride; Cell Line, Tumor; Cell Proliferation; Child; Cladribine; Clofarabine; Cytarabine; Drug Administration Schedule; Drug Synergism; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vidarabine

2016